NASDAQ: SXTC
China Sxt Pharmaceuticals Inc Stock Ownership - Who owns China Sxt Pharmaceuticals?

Insider buying vs selling

Have China Sxt Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SXTC insiders and whales buy or sell their stock.

SXTC Shareholders

What type of owners hold China Sxt Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Invesco Ltd0.65%89,660$126.42kInstitution
Geode Capital Management LLC0.39%53,671$75.68kInstitution
Citadel Advisors LLC0.35%48,759$68.75kInstitution
Renaissance Technologies LLC0.32%44,500$62.75kInstitution
Virtu Financial LLC0.21%28,983$40.87kInstitution
Hrt Financial LP0.19%26,749$37.72kInstitution
Two Sigma Securities LLC0.11%15,449$21.78kInstitution
Tower Research Capital LLC Trc0.02%2,878$4.06kInstitution
Ubs Group Ag0.00%100$141.00Institution
State Of Wyoming0.00%89$125.49Institution

1 of 1

SXTC vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SXTC2.26%0.00%
CABR0.00%27.48%
EVOK4.72%95.28%Net BuyingNet Selling
TXMD3.62%96.38%Net Buying
AYTU10.78%89.22%Net Buying

China Sxt Pharmaceuticals Stock Ownership FAQ

Who owns China Sxt Pharmaceuticals?

China Sxt Pharmaceuticals (NASDAQ: SXTC) is owned by 2.26% institutional shareholders, 0.00% China Sxt Pharmaceuticals insiders, and 97.74% retail investors. Invesco Ltd is the largest individual China Sxt Pharmaceuticals shareholder, owning 89,660.00 shares representing 0.65% of the company. Invesco Ltd's China Sxt Pharmaceuticals shares are currently valued at $126.42k.

If you're new to stock investing, here's how to buy China Sxt Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.